Long-term treatment and prognostic factors of α₁-blockers for lower urinary tract symptoms associated with benign prostatic hyperplasia: A pilot study comparing naftopidil and tamsulosin hydrochloride

By Kawachi Yoshio   Sakurai Toru   Sugimura Sosuke   Iwata Shinji   Noto Kensho   Honda Shin-Ichi   Maruyama Osamu  

Scandinavian Journal of Urology and Nephrology, Vol. 44, Iss. 1, 2010-02 ,pp. : 38-45

Informa Healthcare

Access to resources Recommend Favorite

Short-term efficacy and long-term compliance/treatment failure of the α1 blocker naftopidil for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

By Masumori Naoya   Hashimoto Jiro   Itoh Naoki   Tsukamoto Taiji   Group The Sapporo Medical University Naftopidil Study  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 5, 2007-01 ,pp. : 422-429

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial 1

By Roehrborn C.G.   for the ALFUS STUDY GROUP  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 953-959

Elsevier

Access to resources Recommend Favorite

Incidence and Prevalence of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Primary Care-The Triumph Project

By Verhamme K.M.C.   Dieleman J.P.   Bleumink G.S.   van der Lei J.   Sturkenboom M.C.J.M.   Triumph Pan European Expert Panel  

European Urology, Vol. 42, Iss. 4, 2002-10 ,pp. : 323-328

Elsevier

Access to resources Recommend Favorite

The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia

By Dreikorn Kurt  

World Journal of Urology, Vol. 19, Iss. 6, 2002-04 ,pp. : 426-435

Springer Publishing Company

Access to resources Recommend Favorite